Immediate Assessment for Non-Compliance and Malabsorption
The first step is to directly assess medication adherence, as non-compliance is by far the most common cause of persistently elevated TSH in patients on high-dose levothyroxine (>200 µg/day). 1
Primary Diagnostic Approach
1. Verify Medication Adherence
- Non-compliance is the most common cause of elevated TSH despite high-dose therapy 1
- Directly observe the patient taking their medication or consider supervised dosing
- Review pharmacy refill records (though this alone is unreliable) 2
- Consider a levothyroxine absorption test to distinguish true malabsorption from pseudo-malabsorption (non-compliance):
- Administer 1000 µg levothyroxine orally under direct observation
- Measure free T4 at baseline and 4 hours post-dose
- >50% increase in free T4 from baseline rules out true malabsorption and confirms pseudo-malabsorption 3, 4
- This is a fast, inexpensive outpatient test that prevents unnecessary subspecialty referrals 2
2. Evaluate for Absorption Issues
If compliance is confirmed, investigate factors that impair levothyroxine absorption:
Medication timing and interactions:
- Confirm patient takes levothyroxine on an empty stomach, 30-60 minutes before breakfast with water only 1
- Stop all interfering medications/supplements for at least 4 hours before and after levothyroxine 1:
- Iron supplements
- Calcium supplements
- Antacids
- Proton pump inhibitors
- Other medications listed in guidelines 1
Gastrointestinal conditions:
- Screen for celiac disease, inflammatory bowel disease, atrophic gastritis
- Consider protein-losing enteropathy if albumin is low (<2.5 g/dL) - check stool α-1-antitrypsin 5
- Evaluate for conditions affecting absorption (H. pylori, pancreatic insufficiency)
3. Rule Out Adrenal Insufficiency
- Although rare, adrenal insufficiency can cause elevated TSH that normalizes with glucocorticoid therapy alone 1
- Check morning cortisol and ACTH if clinically indicated
- If adrenal insufficiency is present or suspected, treat with hydrocortisone before increasing levothyroxine to prevent acute adrenal crisis 1, 6
Management Strategy
If Non-Compliance is Confirmed:
- Weekly dosing of levothyroxine (7 times the daily dose once weekly) is a validated alternative with similar safety and efficacy 1
- Implement directly observed therapy initially
- Address barriers to adherence (cost, understanding, depression)
If True Malabsorption is Confirmed:
- Treat underlying gastrointestinal condition
- Consider liquid levothyroxine formulation
- May require doses significantly higher than standard weight-based calculations
- For severe cases, consider intravenous levothyroxine at 70% of oral dose 1
Dose Adjustment Protocol:
- Once adherence/absorption issues are resolved, increase dose by 12.5-25 µg increments 1
- Recheck TSH in 4-8 weeks after any dose change 1
- Continue adjustments until TSH normalizes (goal: 0.3-4.12 mIU/L) 1
Critical Pitfalls to Avoid
- Do not simply increase the dose without investigating the cause - this leads to overtreatment once compliance improves
- Do not overlook cardiovascular risk - if patient has coronary artery disease, monitor closely for angina or arrhythmias when adjusting doses 6
- Do not miss adrenal insufficiency - initiating/increasing levothyroxine without treating concurrent adrenal insufficiency can precipitate adrenal crisis 1, 6
- Do not assume pharmacy records equal compliance - direct observation or absorption testing is more reliable 2
The levothyroxine absorption test is particularly valuable here as it provides definitive evidence within hours and guides whether the issue is behavioral (pseudo-malabsorption requiring adherence support) versus physiologic (true malabsorption requiring higher doses or alternative formulations).